Skip to main content
Log in

Prävalenz respiratorischer Symptome

Aktuelle Datenlage in deutschen Praxen

Prevalence of Respiratory Symptoms. Currently Available Data on German Practices

  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

Zusammenfassung

Atemwegssymptome und Lungenfunktionseinschränkungen sind bei Patienten in Allgemeinarztpraxen häufig. Dabei korrelieren die Beschwerden, insbesondere Belastungsdyspnoe, nur mäßig mit dem Ausmaß der funktionellen Einschränkung. Im Kontrast zu den aktuellen GOLD-Richtlinien orientiert sich die Therapie der COPD in der allgemeinmedizinischen Praxis an Symptomen und weniger an der Lungenfunktion, resultierend in einer Fehlverteilung zulasten beschwerdefreier Patienten. Auch vor dem Hintergrund der krankheitsbedingten Kosten erscheinen zum einen die vermehrte Anwendung der Spirometrie in der Praxis, zum anderen das verstärkte Augenmerk auf die Symptome in den GOLD-Richtlinien erforderlich.

Abstract

Respiratory symptoms and lung function impairment as an expression of COPD are frequent in Germany. The symptoms, especially dyspnea, correlate only moderately with the degree of functional impairment. In contrast to the actual GOLD guidelines, in general practices the therapy is based on symptoms rather than on lung function, resulting in an undertreatment of asymptomatic patients. Therefore, increasing utilization of spirometry in practices is to demand; on the other hand respiratory symptoms should gain a greater significance in the GOLD guidelines, also against the background of disease-related costs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report, Executive Summary, 2001. National Institutes of Health. National Heart, Lung, and Blood Institute. World Health Organisation (https://doi.org/www.goldcopd.com).

  2. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO study. Chest 2004;125:1394–9.

    Article  Google Scholar 

  3. Beeh KM, et al. A descriptive analysis of COPD patients in a large cohort in private practices in Germany. Orlando: American Thoracic Society, 2004.abstract F28.

  4. Tzanakis N, Anagnostopoulou U, Filaditaki V, et al. Prevalence of COPD in Greece. Chest 2004;125:892–900.

    Article  Google Scholar 

  5. Nowak D, Dietrich ES, Oberender P, et al. Krankheitskosten von COPD in Deutschland. Pneumologie 2004;58:837–44.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helgo Magnussen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magnussen, H. Prävalenz respiratorischer Symptome. Med Klin 100 (Suppl 1), 1–4 (2005). https://doi.org/10.1007/BF03403438

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03403438

Schlüsselwörter

Key Words

Navigation